Hep C – Test, Treat, Cure
Blenheim is at the centre of the growing demands for action concerning the failure to treat those with hepatitis C. We are involved in an emergent strategy to support, facilitate and enable those focusing on hepatitis C to achieve the best possible outcomes.
90% of people with hepatitis C in the UK contracted it from injected drug use. It has serious health consequences over time often leading to serious liver problems, cancer and death. Whilst treatment is available it is still restricted with only 4% of people being treated each year. Blenheim actively supports a UK wide effort to find, test, treat and cure whilst continue to campaign for wider treatment.
92% of Blenheim’s new service users that inject drugs or have previously injected drugs had a hepatitis C test
We are advocating that substance misuse agencies, the NHS and local authorities must do more to test, treat and cure those with hepatitis C. We are campaigning for Public Health England (PHE) to include a question on Treatment Outcome Profiles (TOPS) asking if hepatitis C positive service user are receiving treatment. This would provide adequate baseline information to develop an improvement plan.
At Blenheim we are finding those with hepatitis C and advocating and facilitating their access to treatment. We are introducing a range of initiatives in partnership with PHE, Hepatitis C Trust and the London Joint Working Group on Hepatitis C.
Blenheim is a member of the Hepatitis C Coalition which is seeking to influence Government to improve hepatitis C treatment and an emergent partnership strategy to support, facilitate and enable those focusing on hepatitis C to achieve the best possible outcomes.
Blenheim is supporting service users to fight for their right to treatment and exploring how we help advocate for service users to ensure access. See the Blenheim Hepatitis C Strategy 2018 – 2020 for more information about what steps we are making support the elimination of hepatitis C.
You can find more information about hepatitis C on our factsheet.